A0A2J8NM15 (A0A2J8NM15_PANTR) Pan troglodytes (Chimpanzee)
ADAM17 isoform 3 UniProtKBInterProSTRINGInteractive Modelling
824 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: P78536, B2RNB2; Pan paniscus: A0A2R9BL62
It is possible new templates exist for this target since these models were created.
Available Structures
24 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of the TACE-N-TIMP-3 complex |
Heteromer P35625; P78536; | 1×ZN; 1×NA; | ||||
| Assess | ||||||
| Crystal structure of the PTPN3 PDZ domain bound to the PBM TACE C-terminal peptide |
Heteromer P26045; P78536; | 2×NA; | ||||
| Assess | ||||||
| Crystal structure analysis 0f the TNF-a Coverting Enzyme (TACE) in complexed with Aryl-sulfonamide | monomer | 1×ZN; 1×283; | ||||
| Assess | ||||||
| Crystal structure of TACE in complex with IK682 | monomer | 1×ZN; 1×541; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with the first hydantoin inhibitor occupying the S1' … | monomer | 1×ZN; 1×724; | ||||
| Assess | ||||||
| Novel thio-based TACE inhibitors Part 2: Rational design, synthesis and SAR of thiol-contaning aryl… | monomer | 2×ZN; 1×440; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TNF-alpha converting enzyme (TACE) with inhibitor | monomer | 1×ZN; 1×IH6; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor | monomer | 1×ZN; 1×4NH; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with carboxylate inhibitor | monomer | 1×ZN; 1×INN; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with 2-(2-Aminothiazol-4-yl)pyrrolidine-Based Tartrat… | monomer | 1×IPA; 1×INN; 1×ZN; 1×CA; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with hydroxamate inhibitor | monomer | 1×ZN; 1×INN; 1×CIT; | ||||
| Assess | ||||||
| Crystal structure of the catalytic domain of TACE with Isoindolinone-biphenyl-hydantoin inhibitor | monomer | 1×Z93; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of TACE in complex with JMV 390-1 | monomer | 1×ZN; 1×INN; | ||||
| Assess | ||||||
| Crystal structure of TACE in complex with TAPI-2 | monomer | 1×ZN; 1×CA; 1×INN; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with tartrate-based inhibitor | monomer | 1×ZN; 1×INN; | ||||
| Assess | ||||||
| Crystal structure of the catalytic domain of TACE with Indazolinone-phenyl-hydantoin inhibitor | monomer | 1×ZN; 1×727; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with phenyl-pyrrolidinyl-tartrate inhibitor | monomer | 1×ZN; 1×INN; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of tace with benzimidazolyl-thienyl-tartrate based inhibitor | monomer | 1×ZN; 1×50X; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with hydroxamate inhibitor | monomer | 1×ZN; 1×615; 1×INN; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with hydantoin inhibitor | monomer | 1×ZN; 1×INN; 1×IPA; | ||||
| Assess | ||||||
| Crystal structure of catalytic domain of TACE with inhibitor | monomer | 1×ZN; 1×INN; | ||||
| Assess | ||||||
| CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE) | monomer | 1×ZN; 1×INN; | ||||
| Assess | ||||||
| Crystal Structure of TACE with Tryptophan Sulfonamide Derivative Inhibitor | monomer | 1×792; 1×ZN; | ||||
| Assess | ||||||
| The membran-proximal domain of ADAM17 | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6bdz.1.C | monomer | 0.59 | 1×ZN; | 34.99 | ||
| Assess | ||||||
| 8esv.1.A | monomer | 0.58 | 1×ZN; | 31.94 | ||
| Assess | ||||||
| 2dw0.2.A | monomer | 0.53 | 1×ZN; | 27.07 | ||
| Assess | ||||||